Alpha-lipoic acid (ALA) is a naturally produced antioxidant with strong evidence for improving nerve pain in diabetes, supporting blood sugar control, and protecting cells from oxidative damage. Unlike most antioxidants, ALA works in both water-based and fat-based environments throughout the body, which is why researchers sometimes call it a “universal” antioxidant. It also crosses the blood-brain barrier, giving it reach that vitamins C and E cannot match on their own.
What Makes ALA Unusual as an Antioxidant
Your body produces small amounts of ALA in the mitochondria, the energy-generating structures inside every cell. What sets it apart from other antioxidants is that it stays active in both its oxidized and reduced forms. Most antioxidants become inactive after neutralizing a free radical. ALA’s reduced form, called dihydrolipoic acid, can actually regenerate other spent antioxidants like vitamins E and C, and it boosts levels of glutathione, your body’s most important internal antioxidant.
Because ALA dissolves in both water and fat, it can work inside cell membranes and in the watery spaces between cells. This dual solubility lets it reach tissues that many other antioxidants cannot, including the brain and nervous system. It also binds to metals like iron and copper that would otherwise generate damaging free radicals.
Nerve Pain and Diabetic Neuropathy
The best-studied use of ALA is for diabetic neuropathy, the nerve damage that causes pain, tingling, and numbness in the hands and feet of people with diabetes. A meta-analysis of over 1,250 patients found that 600 mg of ALA daily for three weeks reduced pain, tingling sensations, and numbness. Oral supplementation for five weeks produced similar improvements in a separate trial of 187 patients with diabetic nerve damage.
In a longer trial lasting seven months with 509 participants, ALA didn’t significantly reduce subjective symptoms compared to placebo, but objective measurements of nerve function did improve. The takeaway is that ALA appears to genuinely improve how nerves function, though the degree of symptom relief can vary. The 600 mg daily dose is the most consistently supported in clinical research.
Blood Sugar and Insulin Sensitivity
ALA improves how the body responds to insulin, which makes it relevant for people with type 2 diabetes or prediabetes. In one clinical trial, insulin-mediated glucose disposal (a measure of how efficiently your cells absorb sugar from the blood) increased by about 50% in type 2 diabetes patients receiving ALA intravenously. An oral supplementation trial using 600 to 1,800 mg daily for one month found a 27% improvement in insulin sensitivity across all dose groups compared to placebo.
At 1,200 mg per day taken orally for a month, type 2 diabetes patients improved their glucose disposal enough that it became statistically indistinguishable from people with normal blood sugar. In women with gestational diabetes, doses of 100 to 300 mg daily reduced fasting glucose levels. For people with prediabetes, ALA lowered circulating insulin and improved a key marker of insulin resistance, though it didn’t change blood sugar levels directly.
When combined with standard diabetes medications, ALA has been linked to reductions in HbA1c (a measure of average blood sugar over two to three months), with greater improvements at higher doses. These findings suggest ALA works best as a complement to existing blood sugar management, not a replacement.
Cognitive Function and Brain Health
ALA’s ability to cross the blood-brain barrier has prompted research into its effects on cognitive decline, particularly in Alzheimer’s disease. In a clinical study of Alzheimer’s patients taking 600 mg daily, 43% of those with insulin resistance showed meaningful improvement on a standard dementia assessment, compared to 23% of patients without insulin resistance. Both groups improved more than would be expected from the natural course of the disease.
A smaller, longer-term observation is perhaps more striking. When researchers followed 43 Alzheimer’s patients taking ALA over four years, the rate of cognitive decline appeared dramatically slower compared to untreated patients or those taking standard Alzheimer’s medications, particularly during the second year. An earlier pilot study of nine patients showed stable cognitive scores for a full 12 months. These results are promising but come from relatively small studies, so the effect size in larger populations remains uncertain.
Weight Loss
ALA has a modest but real effect on body weight. A meta-analysis of randomized controlled trials found that people taking ALA lost an average of 1.27 kg (about 2.8 pounds) more than those taking a placebo. That’s not dramatic, but it’s a statistically significant difference, and it happens without any required changes to diet or exercise. ALA likely contributes to weight loss through its effects on energy metabolism and insulin signaling rather than through appetite suppression.
Skin and Anti-Aging
When applied topically, ALA at a 5% concentration has shown efficacy for photo-damaged skin. In a controlled clinical study, a topical ALA formulation reduced facial lines, nearly completely resolved fine lines around the eyes and upper lip, and improved overall skin color and texture. These effects stem from ALA’s antioxidant activity at the skin’s surface, where it helps counter the oxidative damage caused by UV exposure.
R-Form vs. S-Form: Which Type to Choose
ALA supplements come in two mirror-image forms: R-lipoic acid (the form your body naturally produces) and S-lipoic acid (a synthetic byproduct). Most supplements contain a 50/50 mix of both, labeled as “racemic” ALA. The R-form has roughly twice the bioavailability of the S-form, with peak blood concentrations running 40 to 50% higher at the same dose. Research in animal models shows the R-form is also more effective at reducing inflammation and boosting antioxidant activity.
Pure R-lipoic acid supplements cost more and can be less stable, but if you’re taking ALA for a specific health goal, the R-form delivers more active compound per milligram. If you’re using a standard racemic supplement, you’re effectively getting half the stated dose in the biologically preferred form.
Dosage Ranges by Use
The safe range for ALA is 200 to 2,400 mg per day, though the optimal dose depends on what you’re using it for. For diabetic neuropathy, 600 mg daily is the best-supported dose. For blood sugar management, trials have used 600 to 1,800 mg daily, with benefits appearing across that range. For general antioxidant support, 300 to 600 mg daily is typical. Oral doses of 600 to 1,800 mg daily have been used safely for up to six months in clinical settings.
ALA is well absorbed from the gut, though taking it on an empty stomach improves absorption. Side effects are generally mild, with some people reporting stomach discomfort at higher doses.
Interactions and Cautions
If you take levothyroxine for a thyroid condition, ALA may interfere with its absorption. Spacing the two at least four hours apart typically avoids this issue. Some people find it easiest to take their thyroid medication first thing in the morning (or in the middle of the night) and their ALA later in the day with or after a meal.
Because ALA can lower blood sugar, people taking diabetes medications should be aware it may amplify their effects, potentially increasing the risk of hypoglycemia. ALA also chelates metals, which is generally beneficial for reducing oxidative stress. However, people with significant mercury-containing dental fillings have occasionally reported feeling unwell, likely because ALA mobilizes small amounts of mercury from amalgam before the body can clear it.
Food Sources
Your body makes ALA on its own, and it’s also present in food. Organ meats (particularly kidney, heart, and liver), red meat, broccoli, spinach, tomatoes, and Brussels sprouts all contain ALA. However, dietary amounts are far smaller than supplemental doses. You’d need to eat unrealistic quantities of spinach to match even a 300 mg supplement. Food sources contribute to your baseline ALA levels, but supplementation is necessary to reach the doses used in clinical research.